Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000085848 | SCV000780280 | uncertain significance | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075235 | SCV001240849 | uncertain significance | Retinal dystrophy | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000085848 | SCV001408552 | pathogenic | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2241 of the ABCA4 protein (p.Leu2241Val). This variant is present in population databases (rs61748521, gnomAD 0.02%). This missense change has been observed in individual(s) with Stargardt disease (PMID: 29925512; Invitae). ClinVar contains an entry for this variant (Variation ID: 99487). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Ophthalmic Genetics Group, |
RCV003324515 | SCV004030357 | likely pathogenic | Stargardt disease | 2023-07-24 | criteria provided, single submitter | research | Clinical significance based on ACMG v2.0 |
Retina International | RCV000085848 | SCV000117991 | not provided | not provided | no assertion provided | not provided |